Stage II Mycosis Fungoides/Sezary Syndrome

9 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Stage II Mycosis Fungoides/Sezary Syndrome

Record	Firm	Date
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies (NCT01273766)	Wake Forest University Health Sciences	2011-01-01
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562)	City of Hope Medical Center	2010-12-01
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (NCT01053494)	Wake Forest University Health Sciences	2010-04-01
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer (NCT01044745)	University of Nebraska	2009-12-10
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma (NCT00601718)	University of Washington	2007-12-01
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203)	Fred Hutchinson Cancer Center	2007-04-01
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides (NCT00052377)	National Cancer Institute (NCI)	2002-09-01
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies (NCT00040846)	Fred Hutchinson Cancer Center	2001-11-01
506U78 in Treating Patients With Lymphoma (NCT00005080)	National Cancer Institute (NCI)	2000-05-01

Track Stage II Mycosis Fungoides/Sezary Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.